N-terminal deletions of lymphotoxin, their preparation and use

Details N-terminal deletions of lymphotoxin, their preparation and use N-terminal deletions of lymphotoxin, their preparation and use

1987-06-15

1992-10-20

Draper, Garnette D.

Chemistry: natural resins or derivatives; peptides or proteins;

Proteins, i.e., more than 100 amino acid residues

Lymphokines, e.g., interferons, interlukins, etc.

530395, 530820, 930143, 930144, 424 851, 435 695, C07K 1300, A01K 3702

Patent

active

051571064

ABSTRACT:
Polypeptides which differ from lymphotoxin by the absence of amino acids at the N-terminal end of the lymphotoxin are described. The polypeptides can be prepared by gene manipulation and are suitable, alone or in combination with lymphokines, as pharmaceuticals.

REFERENCES:
patent: 4568640 (1986-02-01), Rubin
patent: 4677063 (1987-06-01), Mark et al.
patent: 4677064 (1987-06-01), Mark et al.
patent: 4752575 (1988-06-01), Granger et al.
patent: 4782139 (1988-11-01), DiMarchi
Pennica et al., Nature 312, 1984, pp. 724-729.
Kakutani et al, CA vol. 108, 1988, #92969x.
Iwasa et al, CA vol. 109, 1988, #123811s.
The Journal of Biological Chemistry, vol. 260, No. 4, Feb. 25, 1985, pp. 2334-2344, "Primary Structure of Human Lymphotoxin Derived from 1788 Lymphoblastoid Cell Line", Aggarwal et al.
Rubin et al, PNAS, 82, 1985, p. 6637.
Bachmair et al, Science 234, 1986, pp. 179-186.
Wells et al, Gene 34 (1985) pp. 315-323.
Ruddle and Waksman, J. Exp. Med. 128, 1267-1279; 1968.
Granger and Kolb, J. Immun. 101, 111-120; 1968.
Rosenau, W. Fed. Proc. 27, 34-38; 1968.
Sawada and Osawa, Jap. J. Exp. Med. 46, 263-267; 1976.
Granger et al., J. Cell. Immun. 38, 388-402; 1978.
Rundell and Evans, Immun. 3, 9-18; 1981.
Granger et al. J. Lymphokine Res. 1, 45-49; 1982.
Ruddle et al. J. Lymphokine Res. 2, 23-31, 1983.
Khan et al, Proc. Soc. Exp. Biol. Med. 169, 291-294; 1982.
Papermaster et al. Cancer 45, 1248-1253; 1980.
Ranson et al., J. Natn. Cancer Inst. 69, 741-744; 1982.
Gray et al. Nature 312, 721-724; 1984.
Ruff and Giffort, Lymphokines vol. 2, Pick, E. ed. 235-275 Academic Press New York 1981.
Carswell et al. Proc. Natl. Acad. Sci. 72, 3666-3670; 1975.
Evans, Canc. Immunol. Immunother. 12, 181-190; 1982.
Ruff and Giffort, Infect. Immun. 31, 380-385; 1981.
Williamson et al, Proc. Natl. Acad. Sci. 80, 5397-5401; 1983.
Williams and Bellanti, J. Immunol. 130, 518-520; 1983.
Stone-Wolff et al. J. Exp. Med. 159, 828-843; 1984.
Lee et al, J. Immunol. 133, 1083-1086; 1984.
Powell et al, Lymphokine Res. 4, 13-26; 1985.
Nedwin et al. Nucl. Acid Res. 13, 6361-6373; 1985.
Aggarwal et al. J. Biol. Chem. 259, 686-691; 1984.
Maniatis et al., Molecular Cloning, Cold Spring Harbor Laboratory, 1982.
Beck and Bolmer, Nucl. Acid. Res. 8, 3011-3027; 1980.

Affiliated with

Also associated with

Rating

N-terminal deletions of lymphotoxin, their preparation and use does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with N-terminal deletions of lymphotoxin, their preparation and use, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and N-terminal deletions of lymphotoxin, their preparation and use will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-192904